RE:WAVE =MC $9 M / 2xBIG Cancer Drug approvals in Q4=30 BAGGERWoooooooow !!!
look at this incredible opportunity !
A good source of income for you Realstockycameltoe
Surf on the wave !
LOL
Biofreakster wrote:
LIFETIME OPP guys...
Market Cap C$ 9 Million / 5x Cancer Drugs approved in Europe ,market launch expected next Quarter / 2 additional BIG Cancer Drugs awaiting approval in US and Europe expected to be approved in Q4 2020 / Another 6 Cancer Drugs acquired early this month / Its also a covid 19 gem too = UNDISCOVERED stock with 3000%++ UPSIDE Potential ...A MEGA Lifetime Opp guys ...GLTA
Waverley Pharma (WAVE.V)
Waverley Pharma Announces Signing of Term Sheet to Acquire Exclusive Rights to Market Six Generic Oncology Products in the United States
https://finance.yahoo.com/news/electric-royalties-closes-acquisition-bissett-114500612.html
The brands represented by these six generic products, referred to by the Company as WAV-103, WAV-104, WAV-105, WAV-106, WAV-107 and WAV-108, had combined sales of more than $3 billion USD in 2019.
Pipeline
https://www.waverleypharma.com/generic-product-pipeline.html
WAV-101 is an injectable generic chemotherapy drug development for the treatment of non-small cell lung cancer and other indications. Currently there is no marketed generic version for this product in the United States, and the brand generates yearly revenue of over $1 billion USD. Since regulatory filings have been made in the United States and Europe, Waverley Pharma is seeking a sales and marketing partner for Europe.
WAV-102 is an injectable generic chemotherapy drug developed for the treatment of multiple myeloma and other indications. Currently there is no marketed generic for this product and the brand generates yearly revenue of over $800 million USD. Since regulatory filings have been made in the United States and Europe, Waverley Pharma is seeking a sales and marketing partner for Europe.